Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2018 · 10-Q
Revenue$2.46B$2.46B+8.5% vs Q2 2017 Net Income-$182.78M-$182.78MN/M vs Q2 2017 EPS Diluted-$3.07-$3.07N/M vs Q2 2017 Gross Profit$324,994,000+18.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$27,980,000N/M Free Cash Flowderived$15,238,000N/M Margins · derivedGross margin13.2%+1.1 pt vs Q2 2017
Operating margin-7.0%−8.4 pt vs Q2 2017
Net margin-7.4%−8.3 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 8, 2018 · 39 d after period end